PMC:7228307 / 50368-50602
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1003 | 54-60 | Gene | denotes | CTLA‐4 | Gene:1493 |
| 1004 | 68-73 | Gene | denotes | PD‐L1 | Gene:29126 |
| 1005 | 74-78 | Gene | denotes | PD‐1 | Gene:5133 |
| 1015 | 176-181 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T399 | 225-233 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T101 | 176-181 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T858 | 54-60 | http://purl.obolibrary.org/obo/PR_000001852 | denotes | CTLA‐4 |
| T859 | 68-73 | http://purl.obolibrary.org/obo/CLO_0008407 | denotes | PD‐L1 |
| T860 | 125-132 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signals |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T3637 | 19-29 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T24725 | 68-70 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
| T35015 | 74-76 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1003 | 54-60 | Gene | denotes | CTLA‐4 | Gene:1493 |
| 1004 | 68-73 | Gene | denotes | PD‐L1 | Gene:29126 |
| 1005 | 74-78 | Gene | denotes | PD‐1 | Gene:5133 |
| 1015 | 176-181 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T289 | 0-234 | Sentence | denotes | Indeed, checkpoint inhibitors, such as mAbs targeting CTLA‐4 or the PD‐L1/PD‐1 interaction for the suppression of inhibitory signals that contribute to immune tolerance in the tumor microenvironment, are formatted on an IgG4 backbone. |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T612 | 54-60 | Protein | denotes | CTLA‐4 | https://www.uniprot.org/uniprot/Q9XSI1|https://www.uniprot.org/uniprot/Q9UKN9|https://www.uniprot.org/uniprot/Q9TT02|https://www.uniprot.org/uniprot/Q9QZZ7|https://www.uniprot.org/uniprot/Q9MYX7|https://www.uniprot.org/uniprot/Q96P43|https://www.uniprot.org/uniprot/Q8WXJ1|https://www.uniprot.org/uniprot/Q5S005|https://www.uniprot.org/uniprot/Q53TD5|https://www.uniprot.org/uniprot/Q52MC1|https://www.uniprot.org/uniprot/Q0PP65|https://www.uniprot.org/uniprot/P42072|https://www.uniprot.org/uniprot/P16410|https://www.uniprot.org/uniprot/P09793|https://www.uniprot.org/uniprot/O95653|https://www.uniprot.org/uniprot/E9PDH0|https://www.uniprot.org/uniprot/A0N1S0 |
| T629 | 68-73 | Protein | denotes | PD‐L1 | https://www.uniprot.org/uniprot/Q9NZQ7|https://www.uniprot.org/uniprot/Q9NUZ5|https://www.uniprot.org/uniprot/Q9EP73|https://www.uniprot.org/uniprot/Q6WEX4|https://www.uniprot.org/uniprot/Q66RK1|https://www.uniprot.org/uniprot/Q2V8D5|https://www.uniprot.org/uniprot/Q14CJ2|https://www.uniprot.org/uniprot/B4DU27|https://www.uniprot.org/uniprot/B2RBA2 |
| T638 | 74-78 | Protein | denotes | PD‐1 | https://www.uniprot.org/uniprot/Q7M4M5|https://www.uniprot.org/uniprot/Q6NZ54|https://www.uniprot.org/uniprot/Q3KQW2|https://www.uniprot.org/uniprot/P18621|https://www.uniprot.org/uniprot/J3QL51|https://www.uniprot.org/uniprot/B5ME31|https://www.uniprot.org/uniprot/B4E3C2|https://www.uniprot.org/uniprot/B2R4H3 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T398 | 225-233 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T42 | 176-181 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T38 | 176-181 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T289 | 0-234 | Sentence | denotes | Indeed, checkpoint inhibitors, such as mAbs targeting CTLA‐4 or the PD‐L1/PD‐1 interaction for the suppression of inhibitory signals that contribute to immune tolerance in the tumor microenvironment, are formatted on an IgG4 backbone. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T38 | 176-181 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |